Technical Analysis for RSLS - ReShape Lifesciences, Inc.

Grade Last Price % Change Price Change
F 5.88 4.07% 0.23
RSLS closed up 4.07 percent on Friday, November 1, 2024, on 57 percent of normal volume.
Earnings due: Nov 6
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Bullish Engulfing Bullish 4.07%
Crossed Above 20 DMA Bullish 4.07%
Outside Day Range Expansion 4.07%
Fell Below 20 DMA Bearish 7.89%
Wide Bands Range Expansion 7.89%
Gapped Down Weakness 7.89%
20 DMA Support Bullish -0.84%
Pocket Pivot Bullish Swing Setup -0.84%

   Recent Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

ReShape Lifesciences, Inc. Description

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in October 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Clinical Medicine Obesity Metabolic Disease Neuromodulation Diabetes Mellitus Digestive System Surgery Bariatrics Laparoscopy

Is RSLS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 34.22
52 Week Low 4.6
Average Volume 240,991
200-Day Moving Average 9.93
50-Day Moving Average 6.99
20-Day Moving Average 5.55
10-Day Moving Average 5.83
Average True Range 0.76
RSI (14) 51.92
ADX 45.92
+DI 26.31
-DI 11.41
Chandelier Exit (Long, 3 ATRs) 4.91
Chandelier Exit (Short, 3 ATRs) 6.89
Upper Bollinger Bands 6.34
Lower Bollinger Band 4.77
Percent B (%b) 0.71
BandWidth 28.28
MACD Line -0.28
MACD Signal Line -0.42
MACD Histogram 0.1416
Fundamentals Value
Market Cap 137.93 Million
Num Shares 23.5 Million
EPS -38.56
Price-to-Earnings (P/E) Ratio -0.15
Price-to-Sales 0.45
Price-to-Book 1.49
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.76
Resistance 3 (R3) 6.70 6.35 6.62
Resistance 2 (R2) 6.35 6.12 6.38 6.57
Resistance 1 (R1) 6.11 5.98 6.23 6.17 6.52
Pivot Point 5.76 5.76 5.81 5.79 5.76
Support 1 (S1) 5.52 5.53 5.64 5.59 5.24
Support 2 (S2) 5.17 5.39 5.20 5.19
Support 3 (S3) 4.93 5.17 5.14
Support 4 (S4) 5.00